Cargando…
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers
BACKGROUND: we evaluated the concordance between immunohistochemical p53 staining and TP53 mutations in a series of HGSOC. Moreover, we searched for prognostic differences between p53 overexpression and null expression groups. METHODS: patients affected by HGSOC were included. For each case p53 immu...
Autores principales: | Biatta, Chiara M., Paudice, Michele, Greppi, Marco, Parrella, Veronica, Parodi, Alessia, De Luca, Giuseppa, Cerruti, Gianna Maria, Mammoliti, Serafina, Caroti, Cinzia, Menichini, Paola, Fronza, Gilberto, Pesce, Silvia, Marcenaro, Emanuela, Vellone, Valerio G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480567/ https://www.ncbi.nlm.nih.gov/pubmed/37680633 http://dx.doi.org/10.3389/fimmu.2023.1221605 |
Ejemplares similares
-
Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
por: Paudice, Michele, et al.
Publicado: (2023) -
New Insights into Endometrial Cancer
por: Paleari, Laura, et al.
Publicado: (2021) -
Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
por: Mota, Alba, et al.
Publicado: (2015) -
Female Malignancies and Immunotherapy: What’s New?
por: Pesce, Silvia, et al.
Publicado: (2020) -
The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study
por: De Luca, Giuseppa, et al.
Publicado: (2022)